Histology of Barrett's esophagus and dysplasia

Gastrointestinal Endoscopy Clinics of North America

Volumn 13, Issue 2, 2003, Pages 349-368

  Guindi, Maha ^a,b,d   Riddell, Robert H ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CARDIA; CELL STRUCTURE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DYSPLASIA; ESOPHAGUS MUCOSA; GOBLET CELL; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; OBSERVER VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; REVIEW; SURFACE PROPERTY;

EID: 0037841835     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-5157(03)00005-9     Document Type: Review

References (91)

1. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998;93:1028-32.
2. Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
3. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996;110:614-21.
4. Lewin KJ, Riddell RH, Weinstein WM. Barrett's esophagus. In: Gastrointestinal pathology and its clinical implications. 1st edition. New York: Igaku Shoin; 1992. p. 937-44.
5. Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus-the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998;93:1033-6.
6. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-71.
7. Antonioli DA, Wang HH. Morphology of Barrett's esophagus and Barrett's-associated dysplasia and adenocarcinoma. Gastroenterol Clin North Am 1997;26:495-506.
8. Antonioli DA. Esophagus. In: Henson DE, Albores-Saavedra J, editors. Pathology of incipient neoplasia. 2nd edition. Philadelphia: WB Saunders; 1993. p. 64-84.
9. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
10. Haggitt RC. Pathology of Barrett's esophagus. J Gastrointest Surg 2000;4:117-8.
11. Jass JR. Mucin histochemistry of the columnar epithelium of the esophagus: a retrospective study. J Clin Pathol 1981;34:866-70.
12. Haggitt RC, Reid BJ, Rabinovitch PS, Rubin CE. Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol 1988;131:53-61.
13. Wang HH, Zeroogian JM, Spechler SJ, Goyal RK, Antonioli DA. Prevalence and significance of pancreatic acinar metaplasia at the gastroesophageal junction. Am J Surg Pathol 1996;20: 1507-10.
14. Polkowski W, van Lanschot JJ, ten Kate FJ, et al. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus. Am J Gastroenterol 2000;95: 617-25.
15. Krishnamurthy S, Dayal Y. Pancreatic metaplasia in Barrett's esophagus. An immunohistochemical study. Am J Surg Pathol 1995;19:1172-80.
16. Shields HM, Zwas F, Antonioli DA, et al. Scanning electron microscopy of Barrett's epithelium and its correlation with light microscopy and mucin stains. Gastroenterology 1986;90:1932-41.
17. Sawhney RA, Shields HM, Allan CH, et al. Morphological characterization of the squamocolumnar junction of the esophagus in patients with and without Barrett's epithelium. Dig Dis Sci 1996;41:1088-98.
18. Glickman JN, Chen Y, Antonioli D, et al. Characterization of a distinctive multilayered epithelium associated with Barrett's esophagus [abstract]. Gastroenterology 1999;116:A269.
19. Boch JA, Shields HM, Antonioli DA, et al. Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. Gastroenterology 1997;112:760-5.
20. Glickman JN, Chen YY, Wang HH, et al. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol 2001;25:569-78.
21. Shields HM, Rosenberg SJ, Zwas FR, et al. Prospective evaluation of multilayered epithelium in Barrett's esophagus. Am J Gastroenterol 2001;96:3268-73.
22. Hamilton SR, Smith RR, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988; 19:942-8.
23. Weinstein WM, Ippoliti AF. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc 1996;44:91-5.
24. Kim SL, Waring JP, Spechler SJ, et al. Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group. Gastroenterology 1994;107: 945-9.
25. Voutilainen M, Farkkila M, Mecklin JP, et al. Classical Barrett esophagus contrasted with Barrett-type epithelium at normal-appearing esophagogastric junction. Central Finland Endoscopy Study Group. Scand J Gastroenterol 2000;35:2-9.
26. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-6.
27. Nandurkar S, Talley NJ. Barrett's esophagus: the long and the short of it. Am J Gastroenterol 1999;94:30-40.
28. Weston AP, Krmpotich P, Makdisi WF, et al. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Am J Gastroenterol 1996;91:981-6.
29. Johnston MH, Hammond AS, Laskin W, Jones DM. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996;91:1507-11.
30. Morales TG, Sampliner RE, Bhattacharya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol 1997;92:414-8.
31. Chalasani N, Wo JM, Hunter JG, Waring JP. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sci 1997;42:603-7.
32. Weston AP, Krmpotich PT, Cherian R, et al. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus. Dig Dis Sci 1997;42: 597-602.
33. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998;114: 633-9.
34. Hirota WK, Loughney TM, Lazas DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85.
35. Voutilainen M, Farkkila M, Juhola M, et al. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group. Am J Gastroenterol 1999;94:913-8.
36. Hackelsberger A, Gunther T, Schultze V, et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998;43:17-21.
37. Pereira AD, Suspiro A, Chaves P, et al. Short segments of Barrett's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities? Gut 1998;42:659-62.
38. Trudgill NJ, Suvarna SK, Kapur KC, Riley SA. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997;41:585-9.
39. Burgess JN, Payne WS, Andersen HA, et al. Barrett esophagus: the columnar-epithelial-lined lower esophagus. Mayo Clin Proc 1971;46:728-34.
40. Abrams L, Heath D. Lower esophagus lined with intestinal and gastric epithelia. Thorax 1965;20:66-72.
41. McClave SA, Boyce Jr HW, Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest Endosc 1987;33:413-6.
42. Reid BJ, Rubin CE. When is columnar-lined esophagus premalignant [abstract]? Gastroenterology 1985;88:1552.
43. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy. Am J Surg Pathol 1996;20(Suppl):S31-50.
44. Chandrasoma PT, Der R, Dalton P, et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 2001;25:1188-93.
45. Ormsby AH, Kilgore SP, Goldblum JR, et al. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventive strategies in Barrett's esophagus. Mod Pathol 2000;13:614-20.
46. Guelrud M, Herrera I, Essenfeld H, et al. Intestinal metaplasia of the gastric cardia: a prospective study with enhanced magnification endoscopy. Am J Gastroenterol 2002;97:584-9.
47. Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997;226: 522-30.
48. Der R, Tsao-Wei DD, Demeester T, Lord RV, et al. Carditis: a manifestation of gastroesophageal reflux disease. Am J Surg Pathol 2001;25:245-52.
49. Chandrasoma PT, Der R, Ma Y, et al. Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 2000;24:402-9.
50. Kilgore SP, Ormsby AH, Gramlich TL, et al. The gastric cardia: fact or fiction? Am J Gastroenterol 2000;95:921-4.
51. Zhou H, Greco MA, Daum F, Kahn E. Origin of cardia mucosa: ontogenic consideration. Pediatr Dev Pathol 2001;4:358-63.
52. Ormsby AH, Goldblum JR, Richter JE, et al. The sensitivity and specificity of histologic features in the diagnosis of Barrett's esophagus on routine endoscopy biopsy specimens [abstract]. Am J Clin Pathol 1999;112:A533.
53. Sharma P, Weston AP, Morales T, et al. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 2000;46:9-13.
54. Morales TG, Camargo E, Bhattacharyya A, Sampliner RE. Long-term follow-up of intestinal metaplasia of the gastric cardia. Am J Gastroenterol 2000;95:1677-80.
55. Ormsby AH, Vaezi MF, Richter JE, et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 2000;119:683-90.
56. Glickman JN, Wang H, Das KM, et al. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol 2001;25:87-94.
57. DeMeester SR, Wickramasinghe KS, Lord RV, et al. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol 2002;97:2514-23.
58. Mohammed IA, Streutker CJ, Riddell RH. Utilization of cytokeratin 7 and 20 does not differentiate between Barrett's mucosa and gastric cardia intestinal metaplasia. Mod Pathol 2002;15: 611-6.
59. Couvelard A, Cauvin JM, Goldfain D, et al, and the Groupe d'Etude l'Oesophage de Barrett. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut 2001;49:761-6.
60. Jauregui HO, Davessar K, Hale JH, et al. Mucin histochemistry of intestinal metaplasia in Barrett's esophagus. Mod Pathol 1988;1:188-92.
61. Hassall E. Barrett's esophagus: new definitions and approaches in children. J Pediatr Gastroenterol Nutr 1993;16:345-64.
62. Hamilton SR, Yardley JH. Regenerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology 1977;72:669-75.
63. Groben PA, Siegal GP, Shub MD, et al. Gastroesophageal reflux and esophagitis in infants and children. Perspect Pediatr Pathol 1987;11:124-51.
64. Qualman SJ, Murray RD, McClung HJ, Lucas J. Intestinal metaplasia is age related in Barrett's esophagus. Arch Pathol Lab Med 1990;114:1236-40.
65. Skinner DB, Walther BC, Riddell RH, et al. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983;198:554-65.
66. Sampliner RE, Steinbronn K, Garewal HS, Riddell RH. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence ofanti-reflux surgery. Am J Gastroenterol 1988; 83:510-2.
67. Malesci A, Savarino V, Zentilin P, et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc 1996;44:700-5.
68. Sharma P, Morales TG, Bhattacharyya A, et al. Squamous islands in Barrett's esophagus: what lies underneath? Am J Gastroenterol 1998;93:332-5.
69. Gore S, Healey CJ, Sutton R, et al. Regression of columnar lined (Barrett's) esophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993;7:623-8.
70. Neumann CS, Iqbal TH, Cooper BT. Long term continuous omeprazole treatment of patients with Barrett's esophagus. Aliment Pharmacol Ther 1995;9:451-4.
71. Biddlestone LR, Barham CP, Wilkinson SP, et al. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 1998;22:239-45.
72. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esophagus: clinical update. Am J Gastroenterol 1996;91:1719-23.
73. Laukka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 1995;42:59-63.
74. Shand A, Dallal H, Palmer K, et al. Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation. Gut 2001;48:580-1.
75. Overholt BF, Panjehpour M, Haydek JM, Abbott KB. Photodynamic therapy (PDT) for Barrett's esophagus with dysplasia: long term results [abstract]. Atlanta, Georgia: Dig Dis Week; May 19-25, 2001.
76. Chen YY, Wang HH, Antonioli DA, et al. Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction. Hum Pathol 1999;30:1488-95.
77. Rubio CA, Riddell R. Musculo-fibrous anomaly in Barrett's mucosa with dysplasia. Am J Surg Pathol 1988;12:885-9.
78. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
79. Lewin KJ, Riddell RH, Weinstein WM. Inflammatory bowel disease. In: Gastrointestinal pathology and its clinical implications. 1st edition. New York: Igaku Shoin; 1992. p. 937-44.
80. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001;32:368-78.
81. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4.
82. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
83. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001;32:379-88.
84. Thurberg BL, Duray PH, Odze RD. Polypoid dysplasia in Barrett's esophagus: a clinicopathologic, immunohistochemical, and molecular study of five cases. Hum Pathol 1999;30:745-52.
85. Robertson CS, Mayberry JF, Nicholson DA, et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's esophagus. Br J Surg 1988;75:760-3.
86. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate highgrade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105: 40-50.
87. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81-90.
88. Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999;49: 170-6.
89. Van Sandick JW, van Lanschot JJ, Kuiken BW, et al. Impact of endoscopic biopsy surveillance of Barrett's esophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-22.
90. Montgomery E, Bronner MP, Greenson JK, et al. Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol 2002;97:27-31.
91. Skacel M, Petras RE, Gramlich TL, et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000;95:3383-7.